Molecule of the Week
September 15, 2008
Telcagepant is an unusual compound with many types of functional groups and rings. It is being developed by Merck to combat migraine headaches. The synthesis of the seven-membered ring portion of the molecule, reported in Organic Letters in July, has allowed researchers to produce multigram quantities of telcagepant for preclinical evaluation.
- Get more information on this molecule from CAS (Chemical Abstracts Service)
- Molecule of the Week archive | About MOTW